The temporal association between suicide and comorbid mental disorders in people treated for substance use disorders: a National registry study

被引:0
作者
Myhre, Martin O. [1 ]
Walby, Fredrik A. [1 ]
Bramness, Jorgen G. [2 ,3 ,4 ]
Mehlum, Lars [1 ]
机构
[1] Univ Oslo, Inst Clin Med, Natl Ctr Suicide Res & Prevent, Sognsvannveien 21, N-0372 Oslo, Norway
[2] Norwegian Inst Publ Hlth, Dept Alcohol Tobacco & Drugs, Oslo, Norway
[3] UiT The Arctic Univ Norway, Tromso, Norway
[4] Norwegian Natl Competency Ctr Drug Abuse & Mental, Brumunddal, Norway
关键词
Suicide; Substance use disorders; Comorbid mental disorders; SUD services; Mental health services; DISCHARGE; RATES; DEATH;
D O I
10.1186/s13722-023-00415-9
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background The time after contact with specialized health services for mental health and substance use is associated with an increased risk of suicide, where temporal aspects of suicide and comorbid mental disorders in patients with substance use disorders could be associated. This study aimed to examine the temporal association between time from last treatment contact to suicide and comorbid mental disorders in patients with substance use disorders.Methods This study is a historical prospective case series using nationwide registry data. It included 946 individuals registered the year before suicide with a substance use disorder (F10-F19) in Norway's specialized health services for treating substance use and mental health disorders between 2010 and 2020. The outcome was the number of weeks from the last contact with services to suicide. The exposure was comorbid mental disorders divided into 'no comorbid mental disorder'; 'psychosis or bipolar disorders' (F20-F31), 'depressive or anxiety disorders' (F32-F49); and 'personality disorders' (F60-F69). Covariates included gender, age, last diagnosed substance use disorder, registered deliberate self-harm last year, and the number of in- and outpatient contacts the previous year.Results The number of weeks from last service contact to suicide differed (p = < 0.001) between patients with no comorbid mental disorders (Median = 7; IQR 2-23), psychosis or bipolar disorders (Median = 2; IQR = 1-7), depressive or anxiety disorders (Median = 3; IQR = 1-11) and personality disorders (Median = 1; IQR = 1-5.5). Significantly decreased adjusted incidence rate ratios (aIRR) were found for psychosis or bipolar disorders [aIRR = 0.67 (95% CI 0.53-0.85)] and personality disorders [aIRR = 0.56 (0.42-0.77)] compared to no comorbid mental disorder when adjusted for individual characteristics and service contact. For depressive and anxiety disorders compared to no comorbid mental disorder, the association was significant when adjusted for individual characteristics [aIRR = 0.55 (0.46-0.66)].Conclusions While patients with substance use disorders generally died by suicide a short time after contact with services, patients with comorbid mental disorders died an even shorter time after such contact and significantly shorter than patients without such comorbidities.
引用
收藏
页数:9
相关论文
共 50 条
[41]   Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys [J].
Grucza, Richard A. ;
Abbacchi, Anna M. ;
Przybeck, Thomas R. ;
Gfroerer, Joseph C. .
ADDICTION, 2007, 102 (04) :623-629
[42]   Gender-specific study of recurrent suicide attempts in outpatients with multiple substance use disorders [J].
Icick, R. ;
Vorspan, F. ;
Karsinti, E. ;
Ksouda, K. ;
Lepine, J-P ;
Brousse, G. ;
Mouly, S. ;
Bellivier, F. ;
Bloch, V .
JOURNAL OF AFFECTIVE DISORDERS, 2018, 241 :546-553
[43]   Suicide Attempts in an Italian Population with Substance Use Disorders: Results of a Follow-up Study [J].
Pavarin, Raimondo Maria ;
Fontana, Francesca ;
Pacetti, Monica ;
Sanchini, Samantha .
INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION, 2024, 22 (01) :1-11
[44]   The association between cannabis use and mood disorders: A longitudinal study [J].
Feingold, Daniel ;
Weiser, Mark ;
Rehm, Juergen ;
Lev-Ran, Shaul .
JOURNAL OF AFFECTIVE DISORDERS, 2015, 172 :211-218
[45]   A systematic scoping review of interventions to integrate physical and mental healthcare for people with serious mental illness and substance use disorders [J].
Richardson, Amy ;
Richard, Lauralie ;
Gunter, Kathryn ;
Cunningham, Ruth ;
Hamer, Helen ;
Lockett, Helen ;
Wyeth, Emma ;
Stokes, Tim ;
Burke, Martin ;
Green, Mel ;
Cox, Adell ;
Derrett, Sarah .
JOURNAL OF PSYCHIATRIC RESEARCH, 2020, 128 :52-67
[46]   The Role of Suffering in Relation to Suicide in Persons Experiencing Co-occurring Substance Use Disorders and Mental Health Conditions: A Brief Perspective [J].
Hune, Nicole D. ;
Kimball, Thomas G. .
ALCOHOLISM TREATMENT QUARTERLY, 2022, 40 (01) :93-99
[47]   Associations between substance use disorders and suicide or suicide attempts in people with mental illness: a Danish nation-wide, prospective, register-based study of patients diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality disorder [J].
Ostergaard, Marie L. D. ;
Nordentoft, Merete ;
Hjorthoj, Carsten .
ADDICTION, 2017, 112 (07) :1250-1259
[48]   The role of substance use disorders in the transition from suicide attempt to suicide death: a record linkage study of a Swedish cohort [J].
Edwards, Alexis C. ;
Ohlsson, Henrik ;
Sundquist, Jan ;
Crump, Casey ;
Moscicki, Eve ;
Sundquist, Kristina ;
Kendler, Kenneth S. .
PSYCHOLOGICAL MEDICINE, 2024, 54 (01) :90-97
[49]   Smoking cessation treatment outcomes among people with and without mental and substance use disorders: An observational real-world study [J].
Castaldelli-Maia, Joao Mauricio ;
Loreto, Aline Rodrigues ;
Sales Guimaraes-Pereira, Bruna Beatriz ;
Cavalcanti Carvalho, Carlos Felipe ;
Gil, Felipe ;
Frallonardo, Fernanda Piotto ;
Ismael, Flavia ;
de Andrade, Arthur Guerra ;
Ventriglio, Antonio ;
Richter, Kimber P. ;
Bhugra, Dinesh .
EUROPEAN PSYCHIATRY, 2018, 52 :22-28
[50]   Multiple DSM-5 substance use disorders: A national study of US adults [J].
McCabe, Sean Esteban ;
West, Brady T. ;
Jutkiewicz, Emily M. ;
Boyd, Carol J. .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2017, 32 (05)